Search Page

1

Cite

Share

Green tea polyphenols and cancer chemoprevention: multiple mechanisms and endpoints for phase II trials.

Moyers SB, Kumar NB. Moyers SB, et al. Among authors: kumar nb. Nutr Rev. 2004 May;62(5):204-11. doi: 10.1111/j.1753-4887.2004.tb00041.x. Nutr Rev. 2004. PMID: 15212320 Review.

Cite

Share

2

Cite

Share

A natural musaceas plant extract inhibits proteasome activity and induces apoptosis selectively in human tumor and transformed, but not normal and non-transformed, cells.

Kazi A, Urbizu DA, Kuhn DJ, Acebo AL, Jackson ER, Greenfelder GP, Kumar NB, Dou QP. Kazi A, et al. Among authors: kumar nb. Int J Mol Med. 2003 Dec;12(6):879-87. Int J Mol Med. 2003. PMID: 14612961

Cite

Share

3

Cite

Share

Isoflavones in breast cancer chemoprevention: where do we go from here?

Kumar N, Allen K, Riccardi D, Kazi A, Heine J. Kumar N, et al. Front Biosci. 2004 Sep 1;9:2927-34. doi: 10.2741/1448. Front Biosci. 2004. PMID: 15353326 Review.

Cite

Share

4

Cite

Share

Green tea polyphenols in the prevention of colon cancer.

Kumar N, Shibata D, Helm J, Coppola D, Malafa M. Kumar N, et al. Front Biosci. 2007 Jan 1;12:2309-15. doi: 10.2741/2233. Front Biosci. 2007. PMID: 17127241 Review.

Cite

Share

5

Cite

Share

A Phase II randomized, placebo-controlled clinical trial of purified isoflavones in modulating steroid hormones in men diagnosed with localized prostate cancer.

Kumar NB, Krischer JP, Allen K, Riccardi D, Besterman-Dahan K, Salup R, Kang L, Xu P, Pow-Sang J. Kumar NB, et al. Nutr Cancer. 2007;59(2):163-8. doi: 10.1080/01635580701432678. Nutr Cancer. 2007. PMID: 18001210 Free PMC article. Clinical Trial.

Cite

Share

6

Cite

Share

Safety of purified isoflavones in men with clinically localized prostate cancer.

Kumar NB, Krischer JP, Allen K, Riccardi D, Besterman-Dahan K, Salup R, Kang L, Xu P, Pow-Sang J. Kumar NB, et al. Nutr Cancer. 2007;59(2):169-75. doi: 10.1080/01635580701432660. Nutr Cancer. 2007. PMID: 18001211 Free PMC article. Clinical Trial.

Cite

Share

7

Cite

Share

Lycopene in the prevention of prostate cancer.

Dahan K, Fennal M, Kumar NB. Dahan K, et al. Among authors: kumar nb. J Soc Integr Oncol. 2008 Winter;6(1):29-36. J Soc Integr Oncol. 2008. PMID: 18302908 Review.

Cite

Share

8

Cite

Share

Tea consumption and risk of breast cancer.

Kumar N, Titus-Ernstoff L, Newcomb PA, Trentham-Dietz A, Anic G, Egan KM. Kumar N, et al. Cancer Epidemiol Biomarkers Prev. 2009 Jan;18(1):341-5. doi: 10.1158/1055-9965.EPI-08-0819. Cancer Epidemiol Biomarkers Prev. 2009. PMID: 19124518 Free PMC article.

Cite

Share

9

Cite

Share

New insights into the mechanisms of green tea catechins in the chemoprevention of prostate cancer.

Connors SK, Chornokur G, Kumar NB. Connors SK, et al. Among authors: kumar nb. Nutr Cancer. 2012;64(1):4-22. doi: 10.1080/01635581.2012.630158. Epub 2011 Nov 18. Nutr Cancer. 2012. PMID: 22098273 Free PMC article. Review.

Cite

Share

10

Cite

Share

Challenges and potential solutions to meeting accrual goals in a Phase II chemoprevention trial for prostate cancer.

Kumar N, Crocker T, Smith T, Pow-Sang J, Spiess PE, Egan K, Quinn G, Schell M, Sebti S, Kazi A, Chuang T, Salup R, Helal M, Zagaja G, Trabulsi E, McLarty J, Fazili T, Williams CR, Schreiber F, Slaton J, Anderson JK. Kumar N, et al. Contemp Clin Trials. 2012 Mar;33(2):279-85. doi: 10.1016/j.cct.2011.11.004. Epub 2011 Nov 11. Contemp Clin Trials. 2012. PMID: 22101219 Free PMC article. Clinical Trial.

Cite

Share